DETERMINATION OF REFERENCE VALUES FOR TREC AND KREC IN DRY BLOOD SPOTS OF NEWBORNS FROM DIFFERENT GESTATION AGES IN SVERDLOVSK REGION

As a preparatory stage for implementation of genetic testing for severe combined immunodeficiency under a neonatal screening program, a study was performed in Sverdlovsk Region which concerned quantitative determination of T and B cell neogenesis markers (TREC and KREC, respectively) in blood of conditionally healthy newborns. Archived samples of dry blood spots collected in test-forms for routine neonatal screening were used as biological material for the study of full-term 26 girls and 26 boys who did not exhibit serious illnesses during first year of their life. In addition, we investigated potential effects of foetal gestational age upon the number of TREC and KREC in preterm infants. Blood samples from 55 preterm infants (23 to 36 gestational weeks) were also examined. It was shown that the levels of TREC and KREC increased sequentially with the increased gestation terms, but the quantitative changes of markers showed different dynamics. In this respect, the recommended terms of blood sample collection for SCID screening is entirely consistent with timing of blood sampling for routine newborn screening. An alternative result was obtained with a complete absence of TREC or KREC in blood sample of a newborn, irrespectively of prematurity degree (at valid copy numbers of a control gene) which should serve as an indication for immediate consulting of the child by immunologist and in-depth immunological examination, because it may be a first prognostic sign of a fatal disease. In order to obtain correct cut-off levels for TREC/KREC, additional studies are needed on a larger sample of newborns (1.000 to 5.000), followed by validation of the obtained reference boundaries in studies involving patients with different forms of primary immunodeficiencies.

1. Валиуллина А.Я., Ахмадеева Э.Н., Крывкина Н.Н. Проблемы и перспективы успешного выхаживания и реабилитации детей, родившихся с низкой и экстремально низкой массой тела // Вестник современной клинической медицины, 2013. Т. 6, № 1. С. 34-41. [Valiullina A.Ya., Akhmadeeva E.N., Kryvkina N.N. Problems and prospects for successful nursing and rehabilitation of newborns with low and extremely low body weight. Vestnik sovremennoy klinicheskoy meditsiny = Bulletin of Modern Clinical Medicine, 2013, Vol. 6, no. 1, pp. 34-41. (In Russ.)]

2. Гордукова М.А., Оскорбин И.П., Мишукова О.В., Зимин С.Б., Зиновьева Н.В., Давыдова Н.В., Смирнова А.С., Никитина И.А., Корсунский И.А., Филипенко М.Л., Продеус А.П. Разработка набора реагентов для количественного определения молекул ДНК TREC и KREC в цельной крови и сухих пятнах крови методом мультиплексной ПЦР в режиме реального времени // Медицинская иммунология, 2015. Т. 17, № 5. С. 467-478. [Gordukova M.A., Oskorbin I.P., Mishukova O.V., Zimin S.B., Zinovieva N.V., Davydova N.V., Smirnova A.S., Nikitina I.A., Korsunsky I.A., Filipenko M.L., Prodeus A.P. Development of real-time multiplex pcr for the quantitative determination of TREC’s and KREC’s In whole blood and in dried blood spots. Meditsinskaya immunologiya = Medical Immunology (Russia), 2015, Vol. 17, no. 5, pp. 467-478. (In Russ.) doi:10.15789/1563-0625-2015-5-467-478.

3. Дерябина С.С., Тузанкина И.А., Власова Е.В., Шершнев В.Н. Количественная оценка кольцевых структур TREC и KREC у детей с нарушениями функции иммунной системы на первом году жизни // Медицинская генетика, 2015. № 2. С. 53-54. [Deryabina S.S., Tuzankina I.A., Vlasova E.V., Shershnev V.N. Quantitative assessment of TREC and KREC for children with impaired function of their immune system in the first year of life. Meditsinskaya genetika = Medical Genetics, 2015, no. 2, pp. 53-54. (In Russ.)]

4. Донецкова А.Д., Ярилин А.А. Т-рецепторные эксцизионные кольца и значимость их определения в клинике // Иммунология, 2013. Т. 34, № 4. С. 220-226. [Donetskova A.D., Yarilin A.A. T-receptor excision circles and the significance of their determination in the clinic. Immunologiya = Immunology, 2013, Vol. 34, no. 4, pp. 220-226. (In Russ.)]

5. Кузьменко Н.Б., Варламова Т.В., Мерсиянова И.В. Молекулярно-генетическая диагностика первичных иммунодефицитных состояний: (обзор лит. и собств. клин. наблюдения) // Вопросы гематологии/онкологии и иммунопатологии в педиатрии, 2016. № 1. С. 10-16. [Kuzmenko N.B, Varlamova T.V., Mersiyanova I.V. Molecular genetic diagnosis of primary immunodeficiencies (Review of literature and clinical case reports). Voprosy gematologii/onkologii i immunopatologii v pediatrii = Questions of Hematology/Oncology and Immunopathology in Pediatrics, 2016, no. 1, pp. 10-16. (In Russ.)]

6. Латышева Е.А. Первичные иммунодефициты: состояние проблемы на сегодняшний день: Jmf–центры в России // Вопросы современной педиатрии, 2013. Т. 12, № 6. С. 73-77. Latysheva E.A. Primary immunodeficiency: status of a problem today. Russian network of Jmf-centers. Voprosy sovremennoy pediatrii = Current Pediatrics, 2013, Vol. 12, no. 6, pp. 73-77. (In Russ.)

7. Литвицкий П.Ф., Синельникова Т.Г. Врожденный иммунитет: механизмы реализации и патологические синдромы: ч. 2. // Вопросы современной педиатрии, 2009. Т. 8, № 2. С. 59-67. [Litvitsky P., Sinelnikova T. Inborn immunity: mechanisms of realization and pathological syndromes. Voprosy sovremennoy pediatrii = Current Pediatrics, 2009, Vol. 8, no. 2, pp. 52-58. (In Russ.)]

8. О совершенствовании массового обследования новорожденных детей на наследственные заболевания на территории Свердловской области: приказ Минздрава Свердл. обл. № 166-П от 02.03.2012: [Электронный ресурс] // Электронный фонд правовой и нормативно-технической документации: http://docs. cntd.ru/document/412369518 (дата обращения: 28.04.15). [On the improvement of the mass newborn screening for hereditary diseases in the Sverdlovsk region: the low of Health of the Sverdlovsk region No. 166-P of 02/03/2012: [URL] // Electronic Fund of legal and normative-technical documentation. Access mode: http://docs.cntd.ru/ document/412369518 (date of access: 2015, April 28).

9. Овсянников Д.Ю., Илларионова Т.Ю., Пушко Л.В., Кузьменко Л.Г. Часто болеющие дети: что еще кроме инфекций? // Вопросы современной педиатрии, 2013. Т. 12, № 1. С. 74-86. [Ovsyannikov D.Yu., Illarionova T.Yu., Pushko L.V., Kuz’menko L.G. Frequently ill children: what else besides infections? Voprosy sovremennoy pediatrii = Current Pediatrics, 2013, Vol. 12, no. 1, pp. 74-86. (In Russ.)]

10. Парахонский, А.П. Пути и трудности развития клинической иммунологии // Современные наукоемкие технологии, 2010. № 10. С. 71-75. [Parakhonsky A.P. Ways and difficulties of the clinical immunology development. Sovremennye naukoemkie tekhnologii = Modern Science-Intensive Technologies, 2010, no. 10. pp. 71-75. (In Russ.)]

11. Совершенствование практических подходов в акушерстве и фетальной медицине: информационный бюллетень: рек. Междунар. федерации акушеров-гинекологов (FIGO) 2015 года / под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2015. 8 c. [Recommendations of the International Federation of Obstetricians and Gynecologists (FIGO) 2015. Perfection of practical approaches in obstetrics and fetal medicine. Information Bulletin (Ed. V.E. Radzinsky)]. Moscow: Editorial office of the journal StatusPraesens, 2015. 8 p.

12. Стеганцева М.В., Кустанович А.М., Шарапова С.О., Определение кольцевых структур ДНК Т–клеточного (TREC) и B-клеточного (KREC) рецептора как маркера эффективности функционирования иммунной системы // Актуальные вопросы детской онкологии, гематологии и иммунологии: сб. науч. тр. Минск, 2012. С. 206-214. [Stegantseva M.V., Kustanovich A.M., Sharapova S.O. Determination of T-cell (TREC) and B-cell (KREC) receptor excision circles as a markers for the effectiveness of the immune system functioning. Aktual`nye voprosy detskoy onkologii, gematologii i immunologii: sbornik nauchnykh trudov = Actual Questions of Pediatric Oncology, Hematology and Immunology: a Collection of Scientific Papers, Minsk, 2012, pp. 206-214. (In Russ.)]

13. Тузанкина И.А. К вопросу диагностики иммунопатологии // Медицинская иммунология, 2010. Т. 12, № 6. С. 485-496. [Tuzankina I.A. About problem of immunopathology’s diagnostics. Meditsinskaya immunologiya = Medical Immunology (Russia), 2010, Vol. 12, no. 6, pp. 485-496. (In Russ.)] doi: 10.15789/1563-0625-2010-6-485-496.

14. Щербина А.Ю. Маски первичных иммунодефицитных состояний: проблемы диагностики и терапии // Российский журнал детской гематологии и онкологии, 2016. Т. 3, № 1. С. 52-58. [Shcherbina A.Yu. Masks of primary immunodeficiency disorders: diagnostic and therapeutic problems. Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Children Hematology and Oncology, 2016, Vol. 3, no. 1, pp. 52-58. (In Russ.)

15. Accetta D.J. Cause of death in neonates with inconclusive or abnormal T-cell receptor excision circle assays on newborn screening. J. Clin. Immunol., 2011, Vol. 31, no. 6, pp. 962-967.

16. Adams S.P., Rashid S., Premachandra T., Harvey K., Ifederu A., Wilson M.C., Gaspar H.B. Screening of neonatal UK dried blood spots using a duplex TREC screening assay. J. Clin. Immunol., 2014, Vol. 34, no. 3, pp. 323-330.

17. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nature Reviews Immunology, 2004, Vol. 4, no. 7, pp. 553-564.

18. Arkwright P.D., Gennery A.R. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann. N. Y. Acad. Sci., 2011, Vol. 123, no. 8, pp. 7-14.

19. Audrain M., Thomas C., Mirallie S., Bourgeois N., Sebille V., Rabetrano H., Durand-Zaleski I., Boisson R., Persyn M., Pierres C., Mahlaoui N., Fischer A. Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clin. Immunol., 2014, Vol. 150, no. 2, pp. 137-139.

20. Borte S., von Döbeln U., Fasth A., Wang N., Janzi M., Winiarski J., Sack U., Pan-Hammarström Q., Borte M., Hammarström L. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR. Blood, 2012, Vol. 119, no. 11, pp. 2552-2555.

21. Chapel H., Prevot J., Gaspar H.B., Español T., Bonilla F.A., Solis L., Drabwell J. Primary immune deficiencies – principles of care. Frontiers in Immunology, 2014, Vol. 5, no. 627, pp. 1-15.

22. Chiarini M., Zanotti C., Serana F., Sottini A., Bertoli D., Caimi L., Imberti L. T-cell receptor and K-deleting recombination excision circles in newborn screening of T- and B-cell defects: review of the literature and future challenges. Journal of Public Health Research, 2013, Vol. 2, no. 1, pp. 9-16.

23. Clapp D.W. Developmental regulation of the immune system. Semin. Perinatol., 2006, Vol. 30, no. 2, pp. 69-72.

24. de Felipe B., Olbrich P., Lucenas J.M. Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville. Pediatr. Allergy Immunol., 2016, Vol. 27, no. 1, pp. 70-77.

25. Escobar G.J, Greene J.D., Hulac P., Kincannon E., Bischoff K., Gardner M.N., Armstrong M.A., France E.K. Rehospitalization aſter birth hospitalization: patterns among infants of all gestations. Arch. Dis. Child, 2005, Vol. 90, no. 2, pp. 125-131.

26. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., Hammarström L., Nonoyama S., Ochs H.D., Puck J.M., Roifman C., Seger R., Wedgwood J. Primary immunodeficiency diseases: an update from the international Union of Immunological Societies Primary immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol., 2007, Vol. 120, no. 4, pp. 776-794.

27. Glass H.C., Bonifacio S.L., Chau V., Glidden D., Poskitt K., Barkovich A.J., Ferriero D.M., Miller S.P. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics, 2008, Vol. 122, no. 2, pp. 299-305.

28. Holt P.G., Jones C.A. The development of the immune system during pregnancy and early life. Allergy, 2000,Vol. 55, no. 8, pp. 688-697.

29. Huenecke S., Fryns E., Wittekindt B., Buxmann H., Königs C., Quaiser A., Fischer D., Bremm M., Klingebiel T., Koehl U., Schloesser R., Bochennek K. Percentiles of lymphocyte subsets in preterm infants according to gestational age compared to children and adolescents. Human Immunology, 2016, Vol. 84, no. 5, pp. 291-298.

30. Ito T., Liu Y.J., Kadowaki N. Functional diversity and plasticity of human dendritic cell subsets. Int. J. Hematol., 2005, Vol. 81, no. 3, pp. 188-196.

31. Kalman L., Lindegren M.L., Kobrynski L., Vogt R., Hannon H., Howard J.T., Buckley R. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet. Med., 2004, Vol. 6, no. 1, pp. 16-26.

32. Kwan A., Abraham R.S., Currier R., Brower A., Andruszewski K., Abbott J.K., Baker M., Ballow M., Bartoshesky L.E., Bonilla F.A., Brokopp C., Brooks E., Caggana M., Celestin J., Church J.A., Comeau A.M., Connelly J.A., Cowan M.J., Cunningham-Rundles C., Dasu T., Dave N., De La Morena M.T., Duffner U., Fong C.T., Forbes L., Freedenberg D., Gelfand E.W., Hale J.E., Hanson I.C., Hay B.N., Hu D., Infante A., Johnson D., Kapoor N., Kay D.M., Kohn D.B., Lee R., Lehman H., Lin Z., Lorey F., Abdel-Mageed A., Manning A., McGhee S., Moore T.B., Naides S.J., Notarangelo L.D., Orange J.S., Pai S.Y., Porteus M., Rodriguez R., Romberg N., Routes J., Ruehle M., Rubenstein A., Saavedra-Matiz C.A., Scott G., Scott P.M., Secord E., Seroogy C., Shearer W.T., Siegel S., Silvers S.K., Stiehm E.R., Sugerman R.W., Sullivan J.L., Tanksley S., Tierce M.L. 4th, Verbsky J., Vogel B., Walker R., Walkovich K., Walter J.E., Wasserman R.L., Watson M.S., Weinberg G.A., Weiner L.B., Wood H., Yates A.B., Puck J.M., Bonagura V.R. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA, 2014, Vol. 312, no. 7, pp. 729-738.

33. Kwan A., Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Semin. Perinatol., 2015, Vol. 39, no. 3, pp. 194-205.

34. Nakagawa N., Imai K., Kanegane H., Sato H., Yamada M., Kondoh K., Okada S., Kobayashi M., Agematsu K., Takada H., Mitsuiki N., Oshima K., Ohara O., Suri D., Rawat A., Singh S., Pan-Hammarström Q., Hammarström L., Reichenbach J., Seger R., Ariga T., Hara T., Miyawaki T., Nonoyama S. Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J. Allergy Clin. Immunol., 2011, Vol. 128, no. 1, pp. 223-225.

35. Nolan T., Hands R.E., Bustin S.A. Quantification of mRNA Using Real-Time RT-PCR / T. Nolan, R.E. Hands, S.A. Bustin. Nature Protocols, 2006, Vol. 1, no. 3, pp. 1559-1582.

36. Ou X., Zhao H., Sun H., Yang Z., Xie B., Shi Y., Wu X. Detection and quantification of the age-related sjTREC decline in human peripheral blood. International Journal of Legal Medicine, 2011, Vol.125, no. 4, pp. 603-608.

37. Pérez A., Gurbindo M.D., Resino S., Aguarón A., Muñoz-Fernández MA. NK cell increase in neonates from the preterm to the full-term period of gestation. Neonatology, 2007, Vol. 92, no. 3, pp.158-163.

38. Quinello С., Silveira-Lessa A.L., Ceccon M.E.J.R., Cianciarullo M.A., Carneiro-Sampaio M., Palmeira P. Phenotypic differences in leucocyte populations among healthy preterm and full-term newborns. Scandinavian Journal of Immunology, 2014, Vol. 80, pp. 57-70.

39. Rozmus J., Junker A., Thibodeau M.L., Grenier D., Turvey S.E., Yacoub W., Embree J., Haddad E., Langley J.M., Ramsingh R.M., Singh V.A., Long R., Schultz K.R. Severe combined immunodeficiency (SCID) in Canadian children: A national surveillance study. J. Clin. Immunol., 2013, Vol. 33, no. 8, pp. 1310-1316.

40. Shane A.L., Stoll B.J. Neonatal sepsis: progress towards improved outcomes. Journal of Infection, 2014, Vol. 68, no. 1, pp. 24-32.

41. Sharma A.A., Jen R., Butler A., Lavoie P.M. The developing human preterm neonatal immune system: a case for more research in this area. Clin. Immunol., 2012, Vol. 145, no. 1, pp. 61-68

42. Somech R., Lev A., Simon A.J., Korn D., Garty B.Z., Amariglio N., Rechavi G., Almashanu S., Zlotogora J., Etzioni A. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study. Isr. Med. Assoc. J., 2013, Vol. 15, no. 8, pp. 404-409.

43. Sottini A., Ghidini C., Zanotti C., Chiarini M., Caimi L., Lanfranchi A., Moratto D., Porta F., Imberti L. Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin. Immunol., 2010, Vol. 136, no. 2, pp. 217-227.

44. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., Lemons J.A., Donovan E.F., Stark A.R., Tyson J.E., Oh W., Bauer C.R., Korones S.B., Shankaran S., Laptook A.R., Stevenson D.K., Papile L.A., Poole W.K. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics, 2002, Vol. 110, no. 2, Pt 1, pp. 285-291.

45. Stoll B.J., Hansen N.I., Higgins R.D., Fanaroff A.A., Duara S., Goldberg R., Laptook A., Walsh M., Oh W., Hale E. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr. Infect. Dis. J., 2005, Vol. 24, no. 7, pp. 635-639.

46. van der Spek J., Groenwold R.H., van der Burg M., van Montfrans J.M. TREC based newborn screening for severe combined immunodeficiency disease: a systematic review. J. Clin. Immunol., 2015, Vol. 35, no. 4, pp. 416-430.

47. van Zelm M.C., van der Burg M., Langerak A.W., van Dongen J.J. PID comes full circle: application of V(D)J recombination excision circles in research, diagnostics and newborn screening of primary immunodeficiency disorders. Front. Immunol., 2011, Vol. 2, p. 12.

48. Vogel B.H., Bonagura V., Weinberg G.A., Ballow M., Isabelle J., DiAntonio L., Parker A., Young A., Cunningham-Rundles C., Fong C.T., Celestin J., Lehman H., Rubinstein A., Siegel S., Weiner L., Saavedra-Matiz C., Kay D.M., Caggana M. Newborn screening for SCID in New York State: experience from the first two years. J. Clin. Immunol., 2014, Vol. 34, no. 3, pp. 289-303.

49. Wang M.L., Dorer D.J., Fleming M.P., Catlin E.A. Clinical outcomes of near-term infants. Pediatrics, 2004, Vol. 114, no. 2, pp. 372-376.

50. Whelan M.A., Hwan W.H., Beausoleil J., Hauck WW., McGeady S.J. Infants presenting with recurrent infections and low immunoglobulins: characteristics and analysis of normalization. J. Clin. Immunol., 2006, Vol. 26, no. 1, pp. 7-11.

51. Yu H.H., Lee W.I., Tsai L.P., Hsu L.W., Hu M.H., Hwu W.L. Incidence of severe combined immunodeficiency through newborn screening in a Chinese population. J. Formos Med. Assoc., 2015. Vol. 114, no. 1, pp. 12-16.

52. Zasada M., Kwinta P., Durlak W., Bik-Multanowski M., Madetko-Talowska A., Pietrzyk J.J. Development and Maturation of the Immune System in Preterm Neonates: Results from a Whole Genome Expression Study. BioMed Research International, 2014. Available at: https://www.hindawi.com/journals/bmri/2014/498318/ (Accessed 19 February 2017).